RecruitingPhase 3NCT07499817

Effect of Pentoxyfilline on Endometrial Thickness and Frozen Embryo Transfer Outcomes

Sponsor

Beni-Suef University

Enrollment

100 participants

Start Date

Oct 1, 2023

Study Type

INTERVENTIONAL

Conditions

Infertility IVF Embryo Transfer

Summary

The aim of this work was to investigate the effect of different vasodilators as pentoxifylline in women with unexplained infertility using IVF

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 43 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying (control) and a drug called pentoxifylline 400 mg for people with embryo transfer, ivf, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 43 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGpentoxifylline 400 mg

Once daily in form of (Trental ® Sanofi co.) daily in addition to the above treatment protocol from the first day of the cycle until the day of starting progesterone.

OTHER(control)

estradiol valerate 2 mg. in form of (Cycloprogynova® Bayer Shering Pharma) whitepills starting dose is one pill T.I.D